Previous
Next

Welcome to collaborative research.

Where science, technology
and translation converge

Our formula to develop trailblazing drugs and advance health sciences is based on extreme collaboration between three hubs: ambitious scientific research, ever-evolving technological innovation and a constant translational effort of carrying our breakthroughs from bench to bedside.

Latest breakthroughs

Innovation in medicine is happening right now. Keep up with us.
Fernandez-Checa JC, Bagnaninchi P, Ye H, Sancho-Bru P, Falcon-Perez JM, Royo F, Garcia-Ruiz C, Konu O, Miranda J, Lunov O, Dejneka A, Elfick A, McDonald A, Sullivan GJ, Aithal GP, Lucena MI, Andrade RJ, Fromenty B, Kranendonk M, Cubero FJ, Nelson LJ. Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]. J Hepatol. 2021; 75 (4): 935-959. DOI: 10.1016/j.jhep.2021.06.021

Partners

iMed is a FCT funded research centre but we don't act alone. Every in-house member at imed advances our purpose but we also collaborate with some distinguished external partners.

ULisboa
Faculdade de Farmácia
FCT
República Portuguesa
Example Title
Example Title

Become an insider

Subscribe to Breakthrough, our monthly newsletter.
Back To Top
Come meet us at

Faculdade de Farmácia da Universidade de Lisboa | Av. Professor Gama Pinto
1649-003 Lisboa | Portugal


Phone | +351 217 946 400
Fax | +351 217 946 470
Web | www.imed.ulisboa.pt
Email | imed.ulisboa@ff.ulisboa.pt

Social